Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of (+)-&agr;-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders

Use of (+)-&agr;-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders

US Patent 6380216 · Granted Apr 30, 2002

Estimated economic value: $2,113,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists2012
Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, prepa2008
Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemet2005
Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idi2003
Screening methods for altering circadian rhythms and for human casein kinase I &2003
Use of R- +)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperid2001
Use of (+)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl)ethyl]-4-piperidin 2000
Substituted benzofuranylpiperidine as a nootropic agent1995
Saturated tetracyclic nitrogen heterocycles1993
Hydrogenated nitrogen containing tetracycles having two nonadjacent lactam rings1992
Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants1988
Pharmaceutical compositions having antiepileptic and antineuralgic action1984